Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Anjuli S Nayak. (2008) Mometasone furoate monohydrate nasal spray for the treatment of nasal congestion in allergic rhinitis. Expert Review of Clinical Immunology 4:2, pages 143-155.
Read now
Read now
Anthony D'Urzo. (2007) Mometasone furoate dry-powder inhaler for the control of persistent asthma. Expert Opinion on Pharmacotherapy 8:16, pages 2871-2884.
Read now
Read now
Jill P. Karpel & Harold Nelson. (2007) Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma. Current Medical Research and Opinion 23:11, pages 2897-2911.
Read now
Read now
Beverly E Barton. (2005) Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes. Expert Opinion on Therapeutic Targets 9:4, pages 737-752.
Read now
Read now
Eric Schenkel. (2003) Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis. Expert Opinion on Pharmacotherapy 4:9, pages 1579-1591.
Read now
Read now
Sophija Lebenson, Irene Juozapaitienė, Larisa Kaznacheeva, Elena Vypova, Nataly Otiuskina, Janika Tsadikov & Dmitrij Friedland. (1998) Curative Factors of the Dead Sea and the Mechanisms of Their Impact on Organism. Acta Zoologica Lituanica 8:1, pages 65-70.
Read now
Read now
A. BEETZ, G. MESSER, T. OPPEL, D. VAN BEUNINGEN, R. U. PETER * and P. KIND. (1997) Induction of interleukin 6 by ionizing radiation in a human epithelial cell line: control by corticosteroids. International Journal of Radiation Biology 72:1, pages 33-43.
Read now
Read now
Articles from other publishers (58)
Alessandra Cataldo Russomando, Doron Steinberg, Irith Gati, Ronit Vogt Sionov, Ron Eliashar, Michael Friedman & Menachem Gross. (2023) Sinonasal Stent Coated with Sustained-Release Varnish of Mometasone Furoate Inhibits Pro-Inflammatory Cytokine Release from Macrophages: An In Vitro Study. Pharmaceutics 15:3, pages 1015.
Crossref
Crossref
Sandeep Shrestha, Rupesh Raj Joshi & Swikriti Shrestha. (2023) Efficacy of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. The Egyptian Journal of Otolaryngology 39:1.
Crossref
Crossref
Camille Jacques & Ilaria Floris. (2023) How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International Journal of Molecular Sciences 24:2, pages 1483.
Crossref
Crossref
Sarita Karole, Akash Sagar, Anup K Chakraborty & Kavita R Loksh. (2022) Formulation, development and characterization of topical organogel of mometasone furoate for the treatment of skin disease. Indian Journal of Pharmacy and Pharmacology 9:1, pages 51-56.
Crossref
Crossref
Shyam B. Verma & Uwe Wollina. (2021) Long‐standing recalcitrant subcorneal pustular dermatosis responding to topical mometasone furoate cream. Dermatologic Therapy 35:2.
Crossref
Crossref
Graziella Gomes Rivelli, André Coura Perez, Pedro Henrique Reis Silva, Elionai Cassiana de Lima Gomes, Carolina Paula de Souza Moreira, Edwin Tamashiro, Fabiana Cardoso Pereira Valera, Wilma Terezinha Anselmo-Lima, Gérson Antônio Pianetti & Armando Silva-Cunha. (2021) Biodegradable Electrospun Nanofibers: A New Approach For Rhinosinusitis Treatment. European Journal of Pharmaceutical Sciences 163, pages 105852.
Crossref
Crossref
Aiman Abu Ammar, Maayan Gruber, Patrick Martin, Ohad Stern, Forsan Jahshan, Offir Ertracht, Eyal Sela, Samer Srouji & Eyal Zussman. (2018) Local delivery of mometasone furoate from an eluting endotracheal tube. Journal of Controlled Release 272, pages 54-61.
Crossref
Crossref
Orapan PoachanukoonSittichai KoontongkaewPaopanga MonthanapisutNapaporn Pattanacharoenchai. (2017) Mometasone Furoate Suppresses PMA-Induced MUC-5AC and MUC-2 Production in Human Airway Epithelial Cells. Tuberculosis and Respiratory Diseases 80:1, pages 60.
Crossref
Crossref
K. A. Lyseng-Williamson. (2016) Mometasone furoate 0.1 % ointment and hydrogel: a guide to their use in corticosteroid-responsive dermatoses. Drugs & Therapy Perspectives 32:10, pages 407-413.
Crossref
Crossref
Rosaliana Libro, Sabrina Giacoppo, Placido Bramanti & Emanuela Mazzon. (2016) Is the Wnt/β-catenin pathway involved in the anti-inflammatory activity of glucocorticoids in spinal cord injury?. NeuroReport 27:14, pages 1086-1094.
Crossref
Crossref
Michael CanigaAntonio CabalKhamir MehtaDavid S. RossMalgorzata A. GilJanice D. WoodhouseJoseph EckmanJohn R. NaberMarissa K. CallahanLuciano GoncalvesSusan E. HillRobbie L. McleodFraser McIntoshMark C. FrekeSandra A.G. VisserNeil JohnsonMichael SalmonMilenko Cicmil. (2016) Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions. Journal of Aerosol Medicine and Pulmonary Drug Delivery 29:4, pages 362-377.
Crossref
Crossref
Y K Kuznetsova. (2015) Contact dermatitis as a result of the aggression of the environment. How to treat?. Russian Journal of Allergy 12:5, pages 76-81.
Crossref
Crossref
Tetsuo Kobayashi, Satoshi Ito, Daisuke Kobayashi, Anri Kojima, Atsushi Shimada, Ichiei Narita, Akira Murasawa, Kiyoshi Nakazono & Hiromasa Yoshie. (2015) Interleukin‐6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors. Clinical and Experimental Dental Research 1:2, pages 63-73.
Crossref
Crossref
Fadlullah Aksoy, Remzi Dogan, Ilker Kocak, Bayram Veyseller, Orhan Ozturan & Said Incir. (2015) Effect of Nasal Corticosteroid on Secretory Immunoglobulin A Measured in Rat Nasal Lavage. Otolaryngology–Head and Neck Surgery 153:2, pages 298-301.
Crossref
Crossref
Rafał Pawliczak. (2015) Alergiczny nieżyt nosa – nowoczesne leczenie w świetle wytycznych. Alergologia Polska - Polish Journal of Allergology 2:3, pages 106-110.
Crossref
Crossref
E S Fedenko. (2012) Atopic dermatitis. When and how to use topical corticosteroiods?. Russian Journal of Allergy 9:3, pages 32-36.
Crossref
Crossref
Fadlullah Aksoy, Hasan Demirhan, Gülüm İvgin Bayraktar, Yavuz Selim Yıldırım, Orhan Özturan, Nevriye Gönüllü & Burcu Sapmaz. (2012) Effect of nasal mometasone furoate on the nasal and nasopharyngeal flora. Auris Nasus Larynx 39:2, pages 180-185.
Crossref
Crossref
Joaquim Mullol, Francisco de Borja Callejas, Maria Asunción Martínez-Antón, Eva Méndez-Arancibia, Isam Alobid, Laura Pujols, Antonio Valero, Cesar Picado & Jordi Roca-Ferrer. (2011) Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells. Respiratory Research 12:1.
Crossref
Crossref
E V Sokolovskiy, K N Monakhov, D K Dombrovskaya, Ye V Sokolovsky, K N Monakhov & D K Dombrovskaya. (2011) Skin condition control in patients with chronic skin diseasesusing dermatic products. Vestnik dermatologii i venerologii 87:3, pages 133-136.
Crossref
Crossref
Olav Reikerås, Arthur Helle, Claus Danckert Krohn & Jens Ivar Brox. (2009) Effects of high-dose corticosteroids on post-traumatic inflammatory mediators. Inflammation Research 58:12, pages 891-897.
Crossref
Crossref
H Schäcke, TM Zollner, WD Döcke, H Rehwinkel, S Jaroch, W Skuballa, R Neuhaus, E May, U Zügel & K Asadullah. (2009) Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. British Journal of Pharmacology 158:4, pages 1088-1103.
Crossref
Crossref
Ol'ga Gur'evna Elisyutina, E S Fedenko, O G Elisyutina & E S Fedenko. (2009) Mometasone furoate (Elocom) cream in AD teenagers. Russian Journal of Allergy 6:3, pages 65-69.
Crossref
Crossref
G-S Tiplica & CM Salavastru. (2009) Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris. Journal of the European Academy of Dermatology and Venereology 23:8, pages 905-912.
Crossref
Crossref
Catherine B Small & Ariel Teper. (2009) Efficacy and safety of mometasone furoate nasal spray in allergic rhinitis, acute rhinosinusitis and nasal polyposis. Therapy 6:3, pages 393-406.
Crossref
Crossref
Naazneen Surti, Sachin Naik, Tamishraha Bagchi, B. S. Dwarkanath & Ambikanandan Misra. (2008) Intracellular Delivery of Nanoparticles of an Antiasthmatic Drug. AAPS PharmSciTech 9:1, pages 217-223.
Crossref
Crossref
Heike Schacke, Hartmut Rehwinkel, Khusru Asadullah & Andrew C. B. Cato. (2006) Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Experimental Dermatology 15:8, pages 565-573.
Crossref
Crossref
Susanne Ullmann, Thorsten Hage, Regina Draheim, Ute Egerland, Uwe Oelmüller, Kay Brune & Andreas Pahl. (2004) RNA-Based Drug Screening Using Automated RNA Purification and Real-time RT-PCR1. SLAS Discovery 9:2, pages 95-102.
Crossref
Crossref
Rosa Sale, Federica Sabatini, Michela Silvestri, Laura Serpero, Loredana Petecchia & Giovanni A. Rossi. (2004) Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis. International Immunopharmacology 4:13, pages 1687-1696.
Crossref
Crossref
F Sabatini, M Silvestri, R Sale, L Serpero, M Giuliani, L Scarso, P Favini & G.A Rossi. (2003) Concentration-dependent effects of mometasone furoate and dexamethasone on foetal lung fibroblast functions involved in airway inflammation and remodeling. Pulmonary Pharmacology & Therapeutics 16:5, pages 287-297.
Crossref
Crossref
Anjuli S. Nayak, Guy A. Settipane, Andrew Pedinoff, B.Lauren Charous, Eli O. Meltzer, William W. Busse, S. James Zinreich, Richard R. Lorber, Ger Rikken & Melvyn R. Danzig. (2002) Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Annals of Allergy, Asthma & Immunology 89:3, pages 271-278.
Crossref
Crossref
Xianzhi Zhang, Eeva Moilanen, Ian M Adcock, Mark A Lindsay & Hannu Kankaanranta. (2002) Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sciences 71:13, pages 1523-1534.
Crossref
Crossref
Shelby P. Umland, Robert P. Schleimer & Sebastian L. Johnston. (2002) Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma. Pulmonary Pharmacology & Therapeutics 15:1, pages 35-50.
Crossref
Crossref
Xiaoyong FuChou-Hong TannT. K. Thiruvengadam. (2001) Process Improvements in the Synthesis of Corticosteroid 9,11β-Epoxides. Organic Process Research & Development 5:4, pages 376-382.
Crossref
Crossref
Brian O'Connor, Gérard Bonnaud, Tari Haahtela, Juan Manuel Luna, Herbert Querfurt, Thomas Wegener & Barry N Lutsky. (2001) Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. Annals of Allergy, Asthma & Immunology 86:4, pages 397-404.
Crossref
Crossref
Robert A. Nathan, Anjuli S. Nayak, David F. Graft, Michael Lawrence, Frank J. Picone, Tahir Ahmed, James Wolfe, Mark L. Vanderwalker, Keith B. Nolop & Judy E. Harrison. (2001) Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Annals of Allergy, Asthma & Immunology 86:2, pages 203-210.
Crossref
Crossref
Miriam Sharpe & Blair Jarvis. (2001) Inhaled Mometasone Furoate. Drugs 61:9, pages 1325-1350.
Crossref
Crossref
James P. Kemp, Robert B. Berkowitz, S.David Miller, John J. Murray, Keith Nolop & Judy E. Harrison. (2000) Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. Journal of Allergy and Clinical Immunology 106:3, pages 485-492.
Crossref
Crossref
Stephen T. Holgate, Hasan Arshad, Paul Stryszak & Judy E. Harrison. (2000) Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma. Journal of Allergy and Clinical Immunology 105:5, pages 906-911.
Crossref
Crossref
Carolin Schackert, Hans Christian Korting & Monika Sch??fer-Korting. (2000) Qualitative and Quantitative Assessment of the Benefit???Risk Ratio of Medium Potency Topical Corticosteroids In Vitro and In Vivo. BioDrugs 13:4, pages 267-277.
Crossref
Crossref
Anjuli S. Nayak, Charles Banov, Jonathan Corren, Barry K. Feinstein, Anthony Floreani, Bruce F. Friedman, Alan Goldsobel, Gregory M. Gottschlich, Paul J. Hannaway, Kathy L. Lampl, Robert J. Lapidus, Michael Lawrence, William Lumry, Zev Munk, David Pearlman, Anthony T. Scardella, Eric J. Schenkel, Allen T. Segal, Nathan Segall, Bernard Silverman, Lucy Shneyer, Keith B. Nolop & Judy E. Harrison. (2000) Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma. Annals of Allergy, Asthma & Immunology 84:4, pages 417-424.
Crossref
Crossref
E Schwarz, C Schäfer, J.C Bode & C Bode. (2000) INFLUENCE OF THE MENSTRUAL CYCLE ON THE LPS-INDUCED CYTOKINE RESPONSE OF MONOCYTES. Cytokine 12:4, pages 413-416.
Crossref
Crossref
Alberto Papi, Nikolaos G. Papadopoulos, Klaus Degitz, Stephen T. Holgate & Sebastian L. Johnston. (2000) Corticosteroids inhibit rhinovirus-induced intercellular adhesion molecule-1 up-regulation and promoter activation on respiratory epithelial cells. Journal of Allergy and Clinical Immunology 105:2, pages 318-326.
Crossref
Crossref
Michael P. Schön, Bernhard Homey & Thomas Ruzicka. 2000. Dermatopharmacology of Topical Preparations. Dermatopharmacology of Topical Preparations
179
190
.
Stephen Poole, Fernando de Queiroz Cunha & Sergio Henriques Ferreira. 2000. Pain and Neuroimmune Interactions. Pain and Neuroimmune Interactions
31
54
.
William R. Lumry. (1999) A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis. Journal of Allergy and Clinical Immunology 104:4, pages s150-s159.
Crossref
Crossref
Rb Berkowitz, Di Bernstein, C LaForce, Aj Pedinoff, Ar Rooklin, Crv Damaraju, B Mesarina-wicki & Kb Nolop. (1999)
Onset of action of mometasone furoate nasal spray (NASONEX
®
) in seasonal allergic rhinitis
. Allergy 54:1, pages 64-69.
Crossref
Crossref
Franz von Bruchhausen, Siegfried Ebel, Eberhard Hackenthal, Ulrike Holzgrabe, Margitta Albinus, Gudrun Amschler, Erwin von Angerer, C. Arras-Reiter, Andrea Bauer, Pia Bauer, Winfried Beil, Thorsten Beyrich, Katja Binder, Roswitha Böhme, Hans-Hubertus Borchert, Franz Bossle, Franz Bracher, Helmut Bräunlich, Ellen Bretschneider, Regina Brigelius-Flohé, Kerstin Brinkmann, Axel Büge, Wolfram Christ, Monika Cimbollek, Rolf Daniels, Gerd Dannhardt, Hans-Jürgen Duchstein, Kurt Eger, Petra Eichhorn, Michael Engler, Thomas Erker, Peter Felfe, Alfred Fenyves, Reinhard Fescharek, Carmen Frackenpohl, August Wilhelm Frahm, Margarete Frahm, Volker Franke, Ulrich Franken, Detlef Geffken, Uli Geis, Erika Glusa, Berthold Göber, Peter Ndive Gobina, Werner Golder, Margarete Goppelt-Strübe, Katharina Götte, Erkme Gottstein, Michael Grosam, Markus von Gruchalla, Michael Gütschow, Annette Häfner, Boris Haluszczynski, Achim Harder, Sabine Hartmann, Susanne Hartmann, Dieter Heber, Gerhard Heinemeyer, Eberhard Heller, Dietrich von Herrath, J. Hilfenhaus, Ute Hoffmann-Schollmayer, Bernhard Hofmann, Christian Holpert, Ute Hübner-Steiner, Elisabeth Inkmann, Jens Jürgens, Brigitte Kaiser, Dieter-Abbo Kalbhen, Hans Kemmler, Werner Kiefer, Christoph Klett, Stephanie Klett, Martin Klingmüller, Hans-Peter Klöcking, Gerd Kobal, Axel Kramer, Mareta Kreher, M. Krüger, Markus Kuhn, Marion Sylvia Lehner, Detlef Leopoldt, Georg Liedtke, Detlef Manns, Wolfgang Matthiessen, Andreas Maurer, Wolfgang Meindl, Klaus Menges, Paul Messinger, Frank Peter Meyer, Wolfgang Meyerhof, Manfred Moos, Rudolf Morgenstern, Klaus Müller, Walter E. Müller, Corina Nachtsheim, Tilo Netzer, Michael Neugebauer, Werner Neupert, Peter Nickel, Peter Nuhn, Bernd Nürnberg, H. Oelschläger, Joachim Oertel, Michael Oettel, Hartmut Oßwald, Robert Ott, Tilmann Ott, Thomas Otzen, Peter Pachaly, Helmut Pelzer, Karl-Uwe Petersen, Rainer Pick, Martina Pickert, Andreas Pies, Eberhard Reimann, Joachim Richter, Kai Riecke, Suzanne Ritter, Hans Rommelspacher, Ulrich Rose, Gernot Roth, Gerhard Rücker, Judith Schäfer, Joachim G. Schantl, Helmut Schlager, Hildegard Schleinitz, Max Schmauß, Helmut Schmidhammer, Gerhard Schmidt, Timo Schmidt, B. Schneeweiß, Johannes Schräder, Thomas Schulz, Gert Schulze, Peter Schwanz, Johannes Schweiger, Gisela Skopp, Gisela Skorka, Kai Smolinka, Ulrich Speck, Ralf Stahlmann, Herbert Stein, Karlheinz Stiefvater, Karl-Heinz Surborg, Ulf Sürig, Hubert Szelényi, Istvan Szelenyi, Alfred Täufel, Ruth Thieroff-Ekerdt, Reinhard Troschütz, Michael Verborg, Eugen J. Verspohl, Sabine Vogel, Franz-Josef Volk, Thomas Vorwerk, Jürgen Wallmann, Martin Wenzel, Marion Weyandt-Spangenberg, Sandra Wich, Reinhold Wintersteiger, Frauke Woltmann, Beate Wüst, G. Zilow & A. Kluge. 1999. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
71
233
.
Stephen Poole, Fernando de Queiroz Cunha & Sergio Henriques Ferreira. 1999. Cytokines and Pain. Cytokines and Pain
59
87
.
Cezmi A. Akdis, Thorsten Blesken, Mübeccel Akdis, Sefik S. Alkan, Christoph H. Heusser & Kurt Blaser. (1997) Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cellsin vitro. European Journal of Immunology 27:9, pages 2351-2357.
Crossref
Crossref
S H Ferreira, F Q Cunha, B B Lorenzetti, M A Michelin, M Perretti, R J Flower & S Poole. (2009) Role of lipocortin‐1 in the anti‐hyperalgesic actions of dexamethasone. British Journal of Pharmacology 121:5, pages 883-888.
Crossref
Crossref
I Caroline Crocker, Chang Yi Zhou, Againdra K Bewtra, William Kreutner & Robert G Townley. (1997) Glucocorticosteroids Inhibit Leukotriene Production. Annals of Allergy, Asthma & Immunology 78:5, pages 497-505.
Crossref
Crossref
C. A. Akdis. 1997. Strategies for Immunointerventions in Dermatology. Strategies for Immunointerventions in Dermatology
131
146
.
Jayaram R. Tagat, Stuart W. McCombie, Beverly E. Barton, James Jackson & Jennifer Shortall. (1995) Synthetic inhibitors of interleukin-6 II: 3,5-diaryl pyridines and meta-terphenyls. Bioorganic & Medicinal Chemistry Letters 5:18, pages 2143-2146.
Crossref
Crossref
Jayaram R. Tagat, Dennis V. Nazareno, Stuart W. McCombie, Beverly E. Barton, Jennifer Shortall & James Jackson. (1995) Synthetic inhibitors of interleukin-6 I: 2,3,7,8-tetrahydro-4-aryl-1H-cyclopent [e] imidazo [1,2-a]- pyridin-5(6H)-one and related compounds. Bioorganic & Medicinal Chemistry Letters 5:18, pages 2139-2142.
Crossref
Crossref
L. Kemény, G. Michel, A. Dobozy & T. Ruzicka. (2006) Cytokine system as potential target for antipsoriatic therapy. Experimental Dermatology 3:1, pages 1-8.
Crossref
Crossref
J. C. LEE, A. M. BADGER, D. E. GRISWOLD, D. DUNNINGTON, A. TRUNEH, B. VOTTA, J. R. WHITE, P. R. YOUNG & P. E. BENDER. (2006) Bicyclic Imidazoles as a Novel Class of Cytokine Biosynthesis Inhibitors. Annals of the New York Academy of Sciences 696:1, pages 149-170.
Crossref
Crossref
F.Q. Cunha, S. Poole, B.B. Lorenzetti & S.H. Ferreira. (1992) The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. British Journal of Pharmacology 107:3, pages 660-664.
Crossref
Crossref
Kelvin Cooper & Hiroko Masamune. 1992.
209
218
.